AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013
May 10, 2013
30583_dirs_2013-05-10_a84407e3-7e44-4b0c-9575-20b94827e675.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-05-01
Reporting Person: BAFFI ROBERT (EVP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-01 | Common Stock | G | 805 | — | Disposed | 52350 | Direct |
| 2013-05-01 | Common Stock | G | 805 | — | Acquired | 9043 | Indirect |
| 2013-05-08 | Common Stock | F | 2088 | $65.32 | Disposed | 50262 | Direct |
Footnotes
F1: On May 1, 2013 the reporting person gifted 805 shares of Common Stock to his family trust. The reporting person is the trustee.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19